Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis

Background Recent studies have demonstrated that earlier time-of-day infusion of immune checkpoint inhibitors (ICIs) is associated with longer progression-free survival (PFS) and overall survival (OS) among patients with metastatic melanoma and non-small cell lung cancer. These data are in line with...

Full description

Saved in:
Bibliographic Details
Main Authors: Haydn Kissick, Viraj A Master, Mehmet A Bilen, Zachary S Buchwald, Mohammad K Khan, Caroline S Jansen, Michael C Lowe, Jimmy S Patel, Yena Woo, Amber Draper, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, David C Qian
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/3/e008011.full
Tags: Add Tag
No Tags, Be the first to tag this record!